Literature DB >> 32439010

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.

Leslie Cho1, Melinda Davis2, Islam Elgendy3, Kelly Epps4, Kathryn J Lindley5, Puja K Mehta6, Erin D Michos7, Margo Minissian8, Carl Pepine9, Viola Vaccarino10, Annabelle Santos Volgman11.   

Abstract

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee undertook a review of the recent guidelines and major studies to summarize recommendations pertinent to women. In this update, the authors address special topics, particularly the risk factors and treatments that have led to some controversies and confusion. Specifically, sex-related risk factors, hypertension, diabetes, hyperlipidemia, anticoagulation for atrial fibrillation, use of aspirin, perimenopausal hormone therapy, and psychosocial issues are highlighted.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adverse pregnancy outcomes; aspirin; atrial fibrillation; cardiovascular disease; gestational diabetes

Mesh:

Year:  2020        PMID: 32439010      PMCID: PMC8328156          DOI: 10.1016/j.jacc.2020.03.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  135 in total

Review 1.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

2.  Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study.

Authors:  Vanessa Selak; Rod Jackson; Katrina Poppe; Billy Wu; Matire Harwood; Corina Grey; Romana Pylypchuk; Suneela Mehta; Andrew Kerr; Sue Wells
Journal:  Ann Intern Med       Date:  2019-02-26       Impact factor: 25.391

3.  Adverse Cardiovascular Outcomes for Women-Biology, Bias, or Both?

Authors:  Nanette K Wenger
Journal:  JAMA Cardiol       Date:  2020-03-01       Impact factor: 14.676

Review 4.  9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018.

Authors: 
Journal:  Diabetes Care       Date:  2018-01       Impact factor: 19.112

Review 5.  Hypertension Across a Woman's Life Cycle.

Authors:  Nanette K Wenger; Anita Arnold; C Noel Bairey Merz; Rhonda M Cooper-DeHoff; Keith C Ferdinand; Jerome L Fleg; Martha Gulati; Ijeoma Isiadinso; Dipti Itchhaporia; KellyAnn Light-McGroary; Kathryn J Lindley; Jennifer H Mieres; Mary L Rosser; George R Saade; Mary Norine Walsh; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2018-04-24       Impact factor: 24.094

6.  Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus.

Authors:  Alison K Wright; Evangelos Kontopantelis; Richard Emsley; Iain Buchan; Mamas A Mamas; Naveed Sattar; Darren M Ashcroft; Martin K Rutter
Journal:  Circulation       Date:  2019-04-15       Impact factor: 29.690

7.  Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Authors:  Marc S Sabatine; Robert P Giugliano; Anthony C Keech; Narimon Honarpour; Stephen D Wiviott; Sabina A Murphy; Julia F Kuder; Huei Wang; Thomas Liu; Scott M Wasserman; Peter S Sever; Terje R Pedersen
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

8.  Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.

Authors:  John J McNeil; Rory Wolfe; Robyn L Woods; Andrew M Tonkin; Geoffrey A Donnan; Mark R Nelson; Christopher M Reid; Jessica E Lockery; Brenda Kirpach; Elsdon Storey; Raj C Shah; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Colin I Johnston; Joanne Ryan; Barbara Radziszewska; Michael Jelinek; Mobin Malik; Charles B Eaton; Donna Brauer; Geoff Cloud; Erica M Wood; Suzanne E Mahady; Suzanne Satterfield; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

Review 9.  Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis.

Authors:  Clare Teresa Oliver-Williams; Emma E Heydon; Gordon C S Smith; Angela M Wood
Journal:  Heart       Date:  2013-03-28       Impact factor: 5.994

10.  Preterm Delivery and Future Risk of Maternal Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Pensée Wu; Martha Gulati; Chun Shing Kwok; Chun Wai Wong; Aditya Narain; Shaughn O'Brien; Carolyn A Chew-Graham; Ganga Verma; Umesh T Kadam; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2018-01-15       Impact factor: 5.501

View more
  42 in total

Review 1.  Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review.

Authors:  Marina Šprem Goldštajn; Mislav Mikuš; Filippo Alberto Ferrari; Mariachiara Bosco; Stefano Uccella; Marco Noventa; Peter Török; Sanja Terzic; Antonio Simone Laganà; Simone Garzon
Journal:  Arch Gynecol Obstet       Date:  2022-06-17       Impact factor: 2.344

Review 2.  The Diabetes-Cardiovascular Connection in Women: Understanding the Known Risks, Outcomes, and Implications for Care.

Authors:  Eric K Broni; Chiadi E Ndumele; Justin B Echouffo-Tcheugui; Rita R Kalyani; Wendy L Bennett; Erin D Michos
Journal:  Curr Diab Rep       Date:  2022-02-14       Impact factor: 4.810

3.  Smoking and Risk of Premature Atherosclerotic Cardiovascular Disease.

Authors:  Jamal S Rana; Howard H Moffet; Jennifer Y Liu; Khurram Nasir; Ron Blankstein; Andrew J Karter; Stephen Sidney
Journal:  Am J Prev Med       Date:  2021-11-17       Impact factor: 5.043

4.  Sex differences in sleep and psychological disturbances among patients admitted for cardiovascular diseases.

Authors:  Yuichi Jono; Takashi Kohno; Shun Kohsaka; Hiroki Kitakata; Yasuyuki Shiraishi; Yoshinori Katsumata; Kentaro Hayashida; Shinsuke Yuasa; Seiji Takatsuki; Keiichi Fukuda
Journal:  Sleep Breath       Date:  2022-01-06       Impact factor: 2.816

Review 5.  Update on Management of Cardiovascular Diseases in Women.

Authors:  Fabiana Lucà; Maurizio Giuseppe Abrignani; Iris Parrini; Stefania Angela Di Fusco; Simona Giubilato; Carmelo Massimiliano Rao; Laura Piccioni; Laura Cipolletta; Bruno Passaretti; Francesco Giallauria; Angelo Leone; Giuseppina Maura Francese; Carmine Riccio; Sandro Gelsomino; Furio Colivicchi; Michele Massimo Gulizia
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

6.  GPER-dependent estrogen signaling increases cardiac GCN5L1 expression.

Authors:  Janet R Manning; Dharendra Thapa; Manling Zhang; Michael W Stoner; John C Sembrat; Mauricio Rojas; Iain Scott
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-04       Impact factor: 4.733

Review 7.  A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment.

Authors:  Danielle Rome; Alyssa Sales; Rebecca Leeds; John Usseglio; Talea Cornelius; Catherine Monk; Kim G Smolderen; Nathalie Moise
Journal:  Curr Atheroscler Rep       Date:  2022-06-25       Impact factor: 5.967

Review 8.  Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach.

Authors:  Jelani K Grant; Sarah Snow; Michelle Kelsey; Jennifer Rymer; Anna E Schaffer; Manesh R Patel; Robert W McGarrah; Neha J Pagidipati; Nishant P Shah
Journal:  Curr Cardiol Rep       Date:  2022-07-29       Impact factor: 3.955

9.  Central Blood Pressure and Subclinical Atherosclerotic Risk in Young Hispanic American Women.

Authors:  Patricia Pagan Lassalle; Jacob P DeBlois; Allie Keller; Lee Stoner; Kevin S Heffernan
Journal:  Ethn Dis       Date:  2021-10-21       Impact factor: 1.847

Review 10.  Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention.

Authors:  Petal Elder; Garima Sharma; Martha Gulati; Erin D Michos
Journal:  Am J Prev Cardiol       Date:  2020-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.